Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Classement en actions #31187
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Prix de l'action
$0.03808538
Capitalisation boursière
$14.04M
Changement (1 jour)
-3.57%
Changement (1 an)
6.63%
Pays
AU
Échange BCAL Diagnostics Limited (BDX)

Catégorie

Historique des divisions d’actions pour BCAL Diagnostics Limited (BDX)
L’action BCAL Diagnostics Limited (symbole : BDX) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 18, 2026.
Une action BDX achetée avant le Aug 18, 2026 équivaudrait aujourd’hui à 0 actions BDX.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US